Jason Gurda analyst

Currently out of the existing stock ratings of Jason Gurda, 7 are a BUY (100%).

Jason Gurda

Work Performance Price Targets & Ratings Chart

Analyst Jason Gurda, carries an average stock price target met ratio of 83.33% that have a potential upside of 30.37% achieved within 350 days. Previously, Jason Gurda worked at KEYBANK.

Jason Gurda’s has documented 13 price targets and ratings displayed on 4 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on EVHC, Envision Healthcare Holdings at 14-Nov-2017.

Wall Street Analyst Jason Gurda

Analyst best performing recommendations are on MD (MEDNAX).
The best stock recommendation documented was for EVHC (ENVISION HEALTHCARE HOLDINGS) at 11/14/2017. The price target of $40 was fulfilled within 107 days with a profit of $11.48 (40.25%) receiving and performance score of 3.76.

Average potential price target upside

EVHC Envision Healthcare Holdings ACHC Acadia Healthcare Company HCA HCA Holdings MD Mednax

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 01-Mar-2017

$45

$-0.99 (-2.15%)

$85

8 years 7 months 7 days ago
(01-Mar-2018)

1/2 (50%)

$4.98 (12.44%)

168

Buy Since 12-Jun-2014

$41

$-4.99 (-10.85%)

$71

8 years 9 months 19 days ago
(19-Dec-2017)

3/8 (37.5%)

$7.86 (23.72%)

181

Hold Since 03-Dec-2015

$57

8 years 10 months 21 days ago
(17-Nov-2017)

2/5 (40%)

$2.65 (4.88%)

87

Buy Since 20-Aug-2015

$40

$-5.99 (-13.02%)

8 years 10 months 24 days ago
(14-Nov-2017)

1/2 (50%)

$11.48 (40.25%)

107

Buy Since 03-May-2017

$35

$-10.99 (-23.90%)

$73

8 years 10 months 24 days ago
(14-Nov-2017)

1/2 (50%)

$6.48 (22.72%)

49

Show more analysts

Please expand the browser size to see the chart

✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?